877-202-0205     support@chemchart.com     @chemchart
        
Sign In    Register
   Reset Filters

Antineoplastic and immunomodulating drugs, Three-membered rings

Categories

Antineoplastic drugs (8)
Cyclic compounds (8)
Pharmaceuticals (5)
Alkylating antineoplastic agents (4)
Antineoplastic and immunomodulating drug (4)
Aziridines (4)
DNA replication inhibitors (4)
Experimental cancer drugs (3)
Cycloalkanes (2)
Cyclopropanes (2)
Epoxides (2)
Ethers (2)
Six-membered rings (2)
Alcohols (1)
Alkenes (1)
Chalcogenides (1)
Enediynes (1)
Halides (1)
Ketones (1)
Organofluorides (1)
Organohalides (1)
Piperazines (1)
Polycyclic organic compounds (1)
Spiro compounds (1)
Sulfides (1)
Terpenes and terpenoids (1)
Tetracyclic compounds (1)
Thiophosphoryl compounds (1)
Triazines (1)

Suppliers

Matrix Scientific (2)
AK Scientific (1)

thiotepa (52-24-4)  
Triethylenethiophosphoramide  ·  Tespa  ·  Thio Tepa
Thiotepa (INN, chemical name: N,N′,N′′-triethylenethiophosphoramide) is an alkylating agent used to treat cancer. Thiotepa is an organophosphorus compound with the formula SP(NC2H4)3. It is a analog of N,N′,N′′-triethylenephosphoramide (TEPA), which contains tetrahedral phosphorus and is structurally akin to phosphate.
TRIAZIQUONE (68-76-8)  
Trenimon  ·  2,3,5-Tris(ethyleneimine)benzoquinone
Triaziquone is a drug used in chemotherapy. It is an alkylating agent. It can react with DNA to form intrastrand crosslinks.
Triethylenemelamine (51-18-3)  
Triethylene Melamine  ·  Tretamine  ·  2,4,6-Triethylimino-1,3,5-Triazine
Triethylenemelamine (abbreviated TEM, also called Tretamine) is a drug used in chemotherapy. It can cause chromatid aberrations in cell models.
Etoglucid (1954-28-5)  
Epodyl  ·  Ethoglucid
Etoglucid is a drug used in chemotherapy.
Irofulven (158440-71-2)  
Irofulven or 6-hydroxymethylacylfulvene (also known as HMAF of MGI-114) is an experimental antitumor agent. It belongs to the family of drugs called alkylating agents. It inhibits the replication of DNA in cell culture.
Zosuquidar Trihydrochloride (167465-36-3)  
Zosuquidar (also LY-335979) is an experimental antineoplastic drug. In 2010, it was announced that a phase III trial for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome did not meet its primary endpoint and Eli Lilly discontinued its development. Zosquidir inhibits P-glycoproteins.
carboquone (24279-91-2)  
Esquinon  ·  Carboquinone  ·  Carbazilquinone
Carboquone is a drug used in chemotherapy.
Related searches
Antineoplastic and immunomodulating drugs
Three-membered rings